Showing results (51-60 of 144) with videos related to
Sort By:
Pageof 15
Expert Opinion on Investigational Drugs|July 5, 2005
The pharmacology of bosentanV Breu, S I Ertel, S Roux, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|July 6, 2000
Pharmacological properties of Ca(V)3.2, a low voltage-activated Ca2+ channel cloned from human heartL Perchenet, A Bénardeau, E A ErtelCanadian Journal of Physiology and Pharmacology|April 1, 1985
In vitro effects of hypoxia and (or) hypercapnic acidosis on the myocardial uptake of digoxinA Sautegeau, J P Clozel, C Saunier, et al.Journal of Cardiovascular Pharmacology|January 1, 1991
Hemodynamic profile of Ro 40-5967 in conscious rats: comparison with diltiazem, verapamil, and amlodipineM Véniant, J P Clozel, P Hess, et al.Circulation|January 1, 1989
Time course of thrombolysis induced by intravenous bolus or infusion of tissue plasminogen activator in a rabbit jugular vein thrombosis modelJ P Clozel, T Tschopp, E Luedin, et al.Journal of Cardiovascular Pharmacology|October 1, 1995
Acute hemodynamic effects of ciprokiren, a novel renin inhibitor, in sodium-depleted dogsJ P Clozel, M Véniant, U Sprecher, et al.Journal of Cardiovascular Pharmacology|December 1, 1994
Role of endothelin during reperfusion after ischemia in isolated perfused rat heartP H Dagassan, V Breu, M Clozel, et al.Journal of Cardiovascular Pharmacology|January 1, 1995
Role of endothelin in spontaneous phasic contraction of human coronary arteriesP H Dagassan, M Clozel, V Breu, et al.Journal of Cardiovascular Pharmacology|May 1, 1996
Mibefradil, a selective calcium T-channel blocker, in stroke-prone spontaneously hypertensive ratsE Vacher, C Richer, P Fornes, et al.Journal of the American College of Cardiology|August 1, 1993
Temporal evolution of endothelial dysfunction in a rat model of chronic heart failureJ R Teerlink, M Clozel, W Fischli, et al.Pageof 15